Point72 Asia (Singapore)’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,302
Closed -$19K 1190
2024
Q4
$19K Sell
6,302
-5,256
-45% -$14.8K 0.01% 678
2024
Q3
$29.2K Sell
11,558
-12,875
-53% -$45.8K 0.01% 769
2024
Q2
$115K Buy
+24,433
New +$129K 0.02% 449

Other funds holding TELA

Point72 Asia (Singapore)'s TELA Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of TELA Bio (TELA) in Q1 2025, closing a stake of 6,302 shares — an estimated $19K sold.

Point72 Asia (Singapore) first reported a position in TELA in Q2 2024 and held it in 3 quarters. The position peaked at $115K in Q2 2024. 50 funds tracked by Wall St. Rank hold TELA as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining TELA Bio position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 6,302 TELA Bio shares in Q1 2025, an estimated $19K.
  • Point72 Asia (Singapore) first reported a position in TELA Bio in Q2 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s TELA Bio position peaked at $115K in Q2 2024.
  • 50 funds tracked by Wall St. Rank held TELA Bio as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.